Siegfried Schmitt, principal consultant, PAREXEL, discusses how to keep up with changing regulations.
The European Pharmacopoeia defines the format and content of monographs for biologicals to keep pace with recent approaches and meet the needs of its users.
Cornell Stamoran, Catalent Pharma Solutions vice-president, is elected to the board of trustees of the Pharma & Biopharma Outsourcing Association.
Rentschler Biotechnologie launches 2000-L single-use bioreactor and announces additional expansion.
As an affiliate member, TraceLink brings serialization expertise to the Pharma & Biopharma Outsourcing Association.
Eight physician groups wrote to the commissioner of FDA to stress the importance of transparency in biosimilar labeling to decrease prescribing risks.
Widespread use and abuse of opioid painkillers is prompting efforts to develop new drugs and formulations that resist abuse while providing relief to legitimate patients.
Boehringer Ingelheim announces FDA approval of Stiolto Respimat inhaler for the treatment of COPD.